Diabetes and COVID-19 in the Outpatient Setting: What Clinicians Need to Know

By clicking the continue button above, I certify I have read the CME/CE/MOC statements below.



Release Date: December 15, 2020
Expiration Date: December 15, 2021


PROGRAM DESCRIPTION
In the 2020 the CDC reported that 13% of the US adult population had diabetes, 95% of whom have type 2 diabetes. In general, patients with diabetes are at increased risk of developing infections and of dying from them. Studies have shown that patients with diabetes are at increased risk of developing COVID-19 and of having more severe pneumonia, uncontrolled inflammation, and a hypercoagulable state. The understanding of the pathophysiology of COVID-19 and how this contributes to the increased risk for patients with diabetes continues to evolve.

The CME/CE-accredited program “Diabetes and COVID-19 in the Outpatient Setting: What Clinicians Need to Know” will provide clinicians who manage patients with diabetes with the most up-to-date information so that they can appropriately advise patients with diabetes on how to avoid infection, monitor patients with diabetes who develop COVID-19, and recognize and manage complications as they occur to minimize morbidity and mortality.

AGENDA
Welcome and introductions
Understanding the Pathophysiology of COVID-19
Risk of COVID-19 for Patients with Diabetes
Recommendations for Managing Patients with Diabetes during the COVID-19 Pandemic


PROGRAM FACULTY
 J. Morgan Freiman, MD, MSc
 Infectious Diseases Physician
 Director of Antimicrobial Stewardship
 Lahey Hospital and Medical Center
 Assistant Professor of Medicine
 Tufts University School of Medicine
 Boston, MA

J. Morgan Freiman, MD, MSc is an Infectious Diseases physician and the Director for the Antimicrobial Stewardship Program at Lahey Hospital and Medical Center in Burlington, MA. She trained in infectious diseases and epidemiology at Boston Medical Center and Boston University School of Public Health, prior to joining the faculty at Tufts Medical School. She worked on the front lines during the COVID-19 pandemic providing care for hundreds of patients and lead a multi-disciplinary committee to create and implement treatment guidelines for her home institution.

 Jay H. Shubrook, DO, FACOFP, FAAFP
 Professor, Primary Care Department
 Director of Clinical Research and Diabetes Services
 Touro University California
 College of Osteopathic Medicine
 Vallejo, CA


Jay H. Shubrook, DO, FACOFP, FAAFP is a board certified Family Physician and a Fellowship Trained Diabetologist. He is a Professor in the Primary Care Department at Touro University California and serves both as the Director of Clinical Research and the Director of Diabetes Services. His passion is to better prepare the primary care workforce on the management of diabetes. His research explores early interventions in prediabetes and type 2 diabetes. He is an Associate Editor of the JAOA and Clinical Diabetes.

 Jennifer M. Trujillo, PharmD, FCCP, BCPS, CDCES, BC-ADM
 Professor
 Skaggs School of Pharmacy and Pharmaceutical Sciences
 University of Colorado Anschutz Medical Campus
 Aurora, CO



Jennifer M. Trujillo, PharmD, FCCP, BCPS, CDCES, BC-ADM is Professor Emerita at Pennington Biomedical in Baton Rouge, LA, and current President of World Obesity Federation. She is Associate Editor-in-Chief of the journal Obesity and has authored more than 200 publications, primarily on obesity. Dr. Ryan’s research focuses on nutrition, obesity and obesity comorbidities. She has been an investigator for various US National Institutes of Health-sponsored studies, including Pounds Lost, DASH (Dietary Approaches to Stop Hypertension), DPP (Diabetes Prevention Program) and the Look AHEAD study. Dr. Ryan’s continuing interests focus on translation of effective weight management into primary care practices. Dr. Ryan served as Co-Chair on the expert panel for the 2013 ACC/AHA/TOS evidence-based Guidelines on the Evaluation and Management of Overweight and Obesity in Adults and was a panel member of the 2015 Endocrine Society Systematic Evidence Review and Guidelines for Medications that Affect Body Weight. She is Co-Chair of the Steering Committee SELECT, a cardiovascular outcome trial of semaglutide.

TARGET AUDIENCE
The intended audience for this educational initiative is clinicians responsible for the daily management of patients with diabetes.

EDUCATIONAL OBJECTIVES
The proposed initiative is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine. At the conclusion of this education, participants should be able to:

This program is designed to address ACPE competencies, including foundational knowledge, and approach to practice and care 

      • Discuss the most current understanding of the pathophysiology of COVID-19
      • Describe factors that increase the risk of COVID-19 for patients with diabetes
      • Integrate recommendations for the safe and effective management of patients with diabetes during the COVID-19 pandemic
      • Provide counsel to patients with diabetes regarding concerns or fears related to COVID-19

PHYSICIAN ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN DESIGNATION STATEMENT
The Potomac Center for Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions regarding CME/CPE credit or the evaluation, please email contact@potomacme.org.

ABIM MOC DESIGNATION STATEMENT
 Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through PCME's ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

PHARMACIST ACCREDITATION STATEMENT
The Potomac Center for Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


For information about this continuing pharmacy education (CPE) activity, please email: contact@potomacme.org.

PHARMACIST CREDIT DESIGNATION STATEMENT
The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 contact hour (0.10 CEUs) of continuing education credit (UAN number 0418-9999-20-008-H01-P).

This is an application based activity.

DISCLOSURE INFORMATION
The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

Program Faculty
The faculty, authors and content developers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

J. Morgan Freiman, MD, MSc: Nothing to disclose

Jay H. Shubrook, DO, FACOFP, FAAFP: Consultant/Independent Contractor: Bayer, Lilly, Novo Nordisk, Sanofi

Jennifer M. Trujillo, PharmD, FCCP, BCPS, CDCES, BC-ADM: Honoraria (Advisory Board): Sanofi

Planners and Managers
The planners and mangers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:  

Terry Ann Glauser, MD, MPH: Nothing to disclose

Content Reviewers
The content reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Katie Propst, PhD: Nothing to disclose

FDA DISCLOSURE
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

HARDWARE/SOFTWARE REQUIREMENTS
Please ensure the computer system you plan to use meets the following minimum requirements:
  • Operating System: Windows 98 or higher & Macintosh 2.2 or higher
  • Internet Browser (Mac & Windows): Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher, & Opera 5 or higher
  • Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
  • Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME/CE CREDIT AND MOC POINTS
There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME/CE/MOC activity in its entirety, and then complete the post-test, with a score of 75% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.

Jointly provided by the Potomac Center for Medical Education and Rockpointe

 


This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Lilly USA, LLC and Merck.

Click here for the Rockpointe Privacy Policy


 
Facebook - RockPointe Twitter - RockPointe LinkedIn - RockPointe